Request Deal Involvement

AbbVie completed the acquisition of Cerevel Therapeutics for $8.7bn.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Joele Frank

pr advisors

Joele Frank

Centerview Partners

financial advisors

Centerview Partners

Latham & Watkins

legal advisors

Latham & Watkins

Skadden Arps Slate Meagher & Flom

legal advisors to financial advisors

Skadden Arps Slate Meagher & Flom

Kirkland & Ellis

legal advisors

Kirkland & Ellis

Morgan Stanley

financial advisors

Morgan Stanley

Gibson Dunn & Crutcher

legal advisors

Gibson Dunn & Crutcher

Cleary Gottlieb Steen & Hamilton

legal advisors

Cleary Gottlieb Steen & Hamilton

or

Principals

CEREVEL THERAPEUTICS

target

CEREVEL THERAPEUTICS

ABBVIE INC

bidder

ABBVIE INC

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite